Osiris Therapeutics is developing Prochymal in partnership with the Juvenile Diabetes Research Foundation (JDRF) as a treatment for patients with newly diagnosed type 1 diabetes mellitus. Prochymal, a
Upon issuance, the patent is expected to provide Vicor with patent protection for methods of using a peptide to treat infarctions, such as cardiac or cerebral infarctions. Vicor
Bausch + Lomb said that its Soothe Lubricant eye drops long lasting formula is clinically proven to soothe dry and irritated eyes. The new Soothe Xtra Hydration, for
The expanded agreement builds upon the development and commercialisation collaboration between the two companies announced in January 2009. Onyx Pharmaceuticals is expected to provide $20m in funding to
The study was a randomised, double-blind, placebo controlled trial conducted at 13 centers in the US in patients with genotype 1 chronic hepatitis C, 35% of whom had
Merck & Co has posted a net income of $330.2m for the first quarter of 2010, or $0.09 per diluted share, compared to $1.45bn, or $0.67 per diluted
The license granted by GTG covers the activities of EraGen in relation to its genetic diagnostic and analysis products, limited to US and Canada. Although not a counterparty
Particle Sciences said that MRT technology combines a high shear, high pressure impinging jet processor with expert process development to generate results in bottom-up nanoparticle creation and continuous
The 8 non-antibiotic oral formulations licensed to Alvogen under the agreement comprise products in the high growth therapeutic segments of CNS and Osteoporosis among others. Under this agreement,
The sNDA approval was based on results of a double-blind, randomised, placebo-controlled, two-arm, parallel-group study which enrolled 54 adults with EPI due to CP or pancreatectomy. The primary
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.